Crinetics Pharmaceuticals, Inc. (CRNX) › Total AssetsCrinetics Pharmaceuticals, Inc. (CRNX) — Total AssetsAnnual figures by fiscal year, from SEC filings.2017: $15.60M2018: $171.41M2019: $130.38M2020: $183.44M2021: $351.01M2022: $352.18M2023: $635.35M2024: $1.43B2025: $1.13B$1.13B2017Total Assets (USD)2025Fiscal YearTotal AssetsChange YoY2025$1.13B-21.5%2024$1.43B+125.8%2023$635.35M+80.4%2022$352.18M+0.3%2021$351.01M+91.3%2020$183.44M+40.7%2019$130.38M-23.9%2018$171.41M+999.0%2017$15.60M—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share